Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

  • Michael Anderson, Anish Nadkarni, Leah Cardwell, Hossein Alinia, Steven Feldman
  • Patient Preference and Adherence, July 2017, Dove Medical Press
  • DOI: 10.2147/ppa.s115708

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Michael Anderson